Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Li, Jing ^a   Qiu, Shuang Jian ^a   She, Wei Min ^a   Wang, Fu Ping ^a   Gao, Hong ^a   Li, Lei ^a   Tu, Chuan Tao ^a   Wang, Ji Yao ^a   Shen, Xi Zhong ^a   Jiang, Wei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CONCANAVALIN A; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; INTERLEUKIN 22; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 17; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ CD25- T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL CONTACT; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPLETION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN SYNTHESIS INHIBITION; REGULATORY T LYMPHOCYTE; STELLATE CELL; T LYMPHOCYTE; TH17 CELL;

ADULT; ANIMALS; FEMALE; HEPATITIS B VIRUS; HUMANS; INTERLEUKIN-17; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 84862702754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039307     Document Type: Article

References (31)

1. Lu FM, Zhuang H, (2009) Management of hepatitis B in China. Chin Med J (Engl) 122: 3-4.
2. Sakaguchi S, Yamaguchi T, Nomura T, Ono M, (2008) Regulatory T Cells and Immune Tolerance. Cell 133: 775-787.
3. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G, (2001) Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193: 1303-1310.
4. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, et al. (2005) Regulatory T Cells Contribute to the Impaired Immune Response in Patients With Chronic Hepatitis B Virus Infection. Hepatology 41: 771-778.
5. Peng G, Li S, Wu W, Sun Z, Chen Y, et al. (2008) Circulating CD4+CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunol 123: 57-65.
6. Nan XP, Zhang Y, Yu HT, Li Y, Sun RL, et al. (2010) Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+T cells in patients with chronic hepatitis B virus infection. Viral Immunol 23: 63-70.
7. Zhu J, Paul WE, (2009) Heterogeneity and plasticity of T helper cells. Cell Res 20: 4-12.
8. Weaver CT, Hatton RD, (2009) Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol 9: 883-889.
9. Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, et al. (2010) Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51: 81-91.
10. Zhang JY, Song CH, Shi F, Zhang Z, Fu JL, et al. (2010) Decreased ratio of Treg cells to Th17 correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS One 5: e13869.
11. Zhou L, Chong MM, Littman DR, (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
12. Rong G, Zhou Y, Xiong Y, Zhou L, Geng H, et al. (2009) Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol 156: 217-225.
13. Wang W, Shao S, Jiao Z, Guo M, Xu H, et al. (2012) The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int 32: 887-893.
14. Niu YH, Liu HL, Yin DL, Yi RT, Chen TY, et al. (2011) The balance between intrahepatic IL-17+ T cells and Foxp3+ regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol 12: 47-55.
15. Friedman SL, (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172.
16. Vinas O, Bataller R, Sancho-Bru P, Gines P, Berenguer C, et al. (2003) Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 38: 919-929.
17. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, et al. (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26: 117-129.
18. Yu MC, Chen CH, Liang X, Wang L, Gandhi CR, et al. (2004) Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40: 1312-1321.
19. Chen CH, Kuo LM, Chang Y, Wu W, Goldbach C, et al. (2006) In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 44: 1171-1181.
20. Bissell DM, (2010) Inflammation and hepatic fibrosis. Semin Liver Dis 30: 211-214.
21. European Association For The Study Of The Liver, (2009) EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 50: 227-242.
22. Desmet VJ, GerberM, Hoofnagle JH, MannsM, Scheuer PJ, (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520.
23. Zhang Y, Li P, Li G, Huang X, Meng Q, et al. (2007) The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model. J Surg Res 2007 142: 175-183.
24. Tanabe J, Izawa A, Takemi N, Miyauchi Y, Torii Y, et al. (2007) Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects. Immunology 122: 562-570.
25. Fan Y, Weifeng W, Yuluan Y, Qing K, Yu P, et al. (2011) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation. Virol J 14: 8-17.
26. Liu C, GacaMD, Swenson ES, Vellucci VF, ReissM, et al, (2003) Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 278: 11721-11728.
27. Weng YQ, Qiu SJ, Liu YK, Fan J, Gao Q, et al. (2008) Down-regulation of h-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study. J Cancer Res Clin Oncol 134: 179-186.
28. Stephens LA, Gray D, Anderton SM, (2005) CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc Natl Acad Sci U S A 102: 17418-17423.
29. Wei HX, Chuang YH, Li B, Wei H, Sun R, et al. (2008) CD4+CD25+ Foxp3+ Regulatory T Cells protect against T Cell-Mediated Fulminant Hepatitis in a TGF-β-Dependent Manner in Mice. J Immunol 181: 7221-7229.
30. Mou Z, Jia P, Kuriakose S, Khadem F, Uzonna JE, (2010) Interleukin-17-Mediated Control of Parasitemia in Experimental Trypanosoma congolense Infection in Mice. Infect Immun 78: 5271-5279.
31. Lo Re S, Dumoutier L, Couillin I, Van Vyve C, Yakoub Y, et al. (2010) IL-17A-Producing γδT and Th17 Lymphocytes Mediate Lung Inflammation but Not Fibrosis in Experimental Silicosis. J Immunol 184: 6367-6377.